Bioventus, Inc. Class A BVS
NASDAQ · United States · Health Technology
$13.45-0.18 (-1.32%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 0.22 | 0.22 | +1.7% | $153.21M | -1.4% | +4.2%$13.42→$13.98 |
| Q1 2026 | 2026-05-06 | 0.15 | 0.09 | +66.7% | — | — | -0.3%$10.68→$10.65 |
| Q4 2025 | 2026-03-05 | 0.24 | 0.22 | +9.1% | — | — | -0.7%$8.47→$8.41 |
| Q3 2025 | 2025-11-04 | 0.15 | — | — | — | — | +12.5%$6.56→$7.38 |
| Q4 2024 | 2025-03-11 | 0.15 | 0.08 | +87.5% | — | — | — |
| Q3 2024 | 2024-11-05 | 0.06 | 0.02 | +200.0% | — | — | — |
| Q4 2023 | 2024-03-12 | 0.07 | 0.02 | +250.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.